| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |